The phosphocreatine system powers explosive energy in both skeletal muscle and neurons. Here is every major clinical finding — from Rae 2003 (IQ and working memory) to Benton 2010 (cognitive performance) — plus a complete loading and maintenance protocol.
Creatine (methyl-guanidino-acetic acid) is a naturally occurring compound synthesized in the liver, kidneys, and pancreas from the amino acids arginine, glycine, and methionine. The body produces approximately 1–2g per day endogenously; omnivorous diets contribute another 1–2g from red meat and fish. Vegetarians and vegans produce sufficient creatine but have significantly lower baseline muscle creatine stores — making supplementation particularly impactful in these populations.
The functional molecule is phosphocreatine (PCr), formed when creatine accepts a phosphate group via the enzyme creatine kinase (CK). Phosphocreatine acts as a rapid phosphate donor to ADP, regenerating ATP during the first 6–10 seconds of maximal effort — before oxidative phosphorylation or glycolysis can significantly contribute. This is the ATP-PCr energy system (also called the phosphagen system).
The average person operates at approximately 60–80% of maximal muscle creatine saturation. Supplementing with creatine monohydrate raises intramuscular PCr stores by 15–40% above baseline (Harris et al., 1992 — the original creatine loading study). Higher PCr stores mean more ATP can be regenerated during high-intensity effort, delaying fatigue and enabling more total work per training session.
Creatine also buffers intracellular pH by consuming a proton during PCr breakdown (PCr + ADP + H⁺ → Creatine + ATP), partially explaining reduced fatigue during repeated sprint efforts.
Creatine is absorbed in the small intestine via a sodium-dependent creatine transporter (SLC6A8). Transport into muscle is insulin-dependent — co-ingestion with carbohydrates (and to a lesser extent protein) significantly enhances muscle uptake via GLUT4 and insulin signaling. This is why taking creatine with a meal or post-workout shake (when insulin is elevated) is advantageous over fasted supplementation.
Creatine monohydrate is the most evidence-supported ergogenic supplement in existence. The effect sizes are consistent, reproducible, and have been replicated across populations ranging from trained athletes to sedentary elderly.
A landmark meta-analysis by Rawson and Volek (2003) analyzed 22 randomized controlled trials on creatine and resistance training. Key findings: creatine supplementation increased maximum strength (1-RM measures) by an average of 8% more than placebo, and increased maximum lifting volume (sets × reps × weight) by an average of 14% above placebo. A subsequent meta-analysis by Branch (2003) in the International Journal of Sport Nutrition and Exercise Metabolism confirmed average strength gains of 8–14% above placebo across studies.
Practically, this means a lifter with a 100kg squat 1-RM might gain an additional 8–14kg of strength from creatine supplementation over a training block — on top of normal training adaptations.
Creatine's effect on power output is even more pronounced. Lemon (2002) summarized data showing creatine improves peak power by 5–15% during single maximal efforts and maintains power output across repeated sprints more effectively than placebo. Subjects supplemented with creatine show less power drop-off between sprint 1 and sprint 6 in repeated sprint protocols — a clinically relevant advantage for team sport athletes and anyone doing HIIT.
Creatine drives muscle growth through multiple pathways:
A meta-analysis by Lanhers et al. (2017) in the European Journal of Sport Science confirmed that creatine supplementation during resistance training produces significantly greater lean mass gains than training alone, averaging an additional 0.36 kg of lean mass per week of supplementation in trained individuals.
Creatine benefits are strongest for efforts under 30 seconds (phosphagen-dominant). Benefits diminish for sustained aerobic exercise (>2 minutes), though some evidence suggests benefit for repeated high-intensity efforts within endurance sports (e.g., interval cycling, middle-distance swimming). Creatine does not directly improve VO2max or lactate threshold.
The brain is one of the most metabolically demanding organs in the body, consuming approximately 20% of total body energy despite representing only 2% of body weight. Neurons depend heavily on ATP for action potential maintenance (Na/K-ATPase), synaptic vesicle cycling, and neurotransmitter synthesis. Creatine kinase is expressed in neurons and astrocytes — and brain creatine stores are independently regulated from muscle stores.
The most cited cognitive creatine study: Rae C et al. (2003, Proceedings of the Royal Society B) conducted a double-blind, placebo-controlled crossover trial in 45 young adult vegetarians. Subjects received 5g creatine monohydrate per day for 6 weeks, then crossed over to placebo. Outcomes:
The effect was most pronounced in vegetarians (who have lower baseline brain creatine) — supporting the hypothesis that cognitive benefit scales inversely with baseline creatine status. Vegetarians and vegans are the population most likely to see large cognitive improvements from supplementation.
Benton D and Donohoe R (2011, British Journal of Nutrition) ran a double-blind, placebo-controlled study in 128 healthy young adults (omnivores). Subjects received 5g/day creatine or placebo for 6 weeks. Key findings:
One of the most practically useful creatine findings: McMorris et al. (2006, Neuropsychologia) studied 10 subjects under 24-hour sleep deprivation and found that creatine supplementation significantly reduced the cognitive decline associated with sleep loss. Tasks including random movement generation, backward digit span, and decision-making all showed attenuated decline in the creatine group relative to placebo.
The mechanism is compelling: sleep deprivation impairs the brain's energy metabolism — creatine supplementation maintains ATP availability in neurons under energy-stressed conditions, preserving cognitive function when oxidative phosphorylation is compromised by fatigue.
Brain creatine concentrations decline with age, as does mitochondrial efficiency. Rawson et al. (2008) and subsequent research have demonstrated that creatine supplementation in older adults (>55 years) improves cognition more than in younger subjects — suggesting a re-saturation effect as baseline brain creatine falls with aging. Alves et al. (2013) found improved cognitive performance in elderly women supplementing with creatine during a resistance training program vs training + placebo, with particular improvements in spatial and verbal short-term memory.
Creatine is now studied in the context of neurodegenerative disease. Early Parkinson's and ALS trials suggested possible neuroprotective effects, though large-scale RCTs have not confirmed slowing of disease progression. The most robust brain creatine evidence remains in healthy populations under metabolic stress.
The classic loading protocol (Harris et al., 1992; Hultman et al., 1996) uses 4 × 5g doses per day for 5–7 days to rapidly saturate muscle creatine stores. This fills the creatine pool approximately 3–4 weeks faster than the maintenance approach. Benefits appear within days of completing the loading phase.
Loading is appropriate when: you want fast results, are preparing for a competition, or have a short-term supplementation window. Gastrointestinal discomfort (nausea, cramping) is more common during loading — taking 5g doses with meals and spreading doses throughout the day minimizes this.
Without loading, 3–5g per day reaches equivalent muscle saturation in approximately 28 days (Hultman et al., 1996). There is no meaningful performance difference long-term between loaded and maintenance-only approaches — the loading phase simply gets you to the same endpoint faster. For most people without time pressure, starting directly at 5g/day is the simplest approach.
Body mass influences optimal dose: 0.03g/kg/day is the research-supported minimum for saturation. For a 90kg person, that is 2.7g — meaning the standard 5g recommendation provides a comfortable buffer above the threshold for nearly all body weights.
Post-workout creatine supplementation shows a modest advantage over pre-workout in several trials. Antonio and Ciccone (2013) found significantly greater lean mass and strength gains in the post-workout group over 4 weeks. The mechanism: elevated post-exercise insulin sensitivity enhances creatine transport into muscle. Taking creatine with a carbohydrate- or protein-containing meal also significantly increases muscle uptake vs fasted ingestion (Green et al., 1996).
| Parameter | Creatine Monohydrate | Creatine HCL |
|---|---|---|
| Solubility | ~14g/L (moderate) | ~38× more soluble than monohydrate |
| Human trial evidence | 50+ RCTs; overwhelmingly supported | Very limited — 1–2 small studies |
| Dose required | 5g/day (maintenance) | Claimed 1–2g/day (unverified in trials) |
| Cost per serving | Very low (~$0.10–0.20/dose) | 3–5× more expensive |
| GI tolerance | Good; issues mainly during loading | Claimed better (anecdotal; unconfirmed) |
| Micronized form | Improved solubility; same evidence base | — |
| Verdict | ✅ Evidence-based default | No advantage demonstrated over monohydrate |
Conclusion on forms: Creatine monohydrate — specifically micronized creatine monohydrate — is the evidence-based standard. Creatine HCL, creatine ethyl ester, buffered creatine (Kre-Alkalyn), and other branded forms have not outperformed monohydrate in head-to-head trials. The higher solubility of HCL is a theoretical advantage that has not translated to better outcomes in the small number of available human studies. Buy the cheapest, highest-purity monohydrate available.
This is the most persistent and thoroughly debunked myth about creatine. The confusion arises because creatine metabolism increases serum creatinine — a kidney function marker — but creatinine from creatine supplementation is not indicative of kidney damage. Poortmans and Francaux (1999) studied creatine users for up to 5 years and found no adverse changes in glomerular filtration rate, tubular reabsorption, or other kidney function markers. In healthy individuals, there is no evidence of renal harm at standard doses (3–5g/day). A 2019 systematic review by Farber et al. confirmed no kidney dysfunction in healthy subjects across all reviewed trials. Note: individuals with pre-existing kidney disease should consult a physician before supplementing.
This concern traces to a single small study: van der Merwe et al. (2009) found that creatine supplementation in college rugby players increased serum DHT (dihydrotestosterone) by approximately 56% — without a significant increase in total testosterone. DHT is associated with male pattern baldness in genetically predisposed individuals. However, no study has directly measured hair loss as an outcome after creatine supplementation. The van der Merwe study was small (N=20), not replicated, and the DHT levels remained within the normal physiological range. Current evidence does not support creatine as a meaningful driver of hair loss in most people; those with strong family history of MPB may reasonably exercise caution.
Creatine does increase total body water — but this water is drawn intracellularly into muscle, not subcutaneously. The result is fuller, larger-appearing muscles — not the "puffy" look associated with subcutaneous fluid. Initial weight gain of 1–3 kg during loading is primarily intramuscular water. Micronized creatine monohydrate and lower-dose protocols (skipping loading) minimize GI bloating. There is no evidence of clinically significant edema or cardiovascular burden from creatine-induced water retention.
There is no evidence supporting creatine cycling (e.g., 8 weeks on, 4 weeks off). Creatine does not downregulate the body's synthetic capacity meaningfully — endogenous production decreases slightly during supplementation but normalizes within weeks of stopping. Long-term continuous use has been studied safely for up to 5 years. Cycling is unnecessary and results in periods of suboptimal creatine status.
Creatine is not a steroid, hormone, or controlled substance. It is a naturally occurring molecule synthesized in the body from amino acids. It appears naturally in meat and fish. It is not banned by WADA, the NCAA, or any major sports governing body. It is classified as a dietary supplement.
| Authors | Year | N | Key Finding | Significance |
|---|---|---|---|---|
| Harris et al. | 1992 | 17 | Oral creatine supplementation (20–30g/day) increases muscle creatine by 20% and phosphocreatine by 25% | Foundational study demonstrating oral bioavailability and muscle uptake; established the loading concept |
| Rae et al. | 2003 | 45 | 5g/day × 6 weeks improved working memory (backward digit span) and Raven's IQ matrices in vegetarians (p < 0.0001) | Most cited cognitive creatine RCT; demonstrated neuroenergetic role of creatine in human cognition |
| Rawson & Volek | 2003 | Meta (22 RCTs) | Creatine increased 1-RM strength by 8% and lifting volume by 14% vs placebo during resistance training | Definitive meta-analysis for muscle strength; confirmed consistent effect across populations and exercise protocols |
| McMorris et al. | 2006 | 10 | Creatine significantly attenuated cognitive decline during 24-hour sleep deprivation across multiple tasks | Demonstrated practical cognitive protection under energy-stressed brain conditions; relevant for shift workers and military |
| Benton & Donohoe | 2011 | 128 | 5g/day × 6 weeks improved spatial memory and long-term memory consolidation in omnivores | Extended cognitive creatine evidence to non-vegetarian populations; confirmed memory benefits beyond working memory |
As an Amazon Associate, StackProtocol earns from qualifying purchases made through links on this page. This does not affect the price you pay.